Market Value423,865,875
Total Holdings70
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SRPT / Sarepta Therapeutics, Inc.
MRUS / Merus N.V.
CATX / Perspective Therapeutics, Inc.
IMNM / Immunome, Inc.
GERN / Geron Corporation
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
STOK / Stoke Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
INSM / Insmed Incorporated Call
INSM / Insmed Incorporated
GUTS / Fractyl Health, Inc.
VYNE / VYNE Therapeutics Inc.
XENE / Xenon Pharmaceuticals Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
APGE / Apogee Therapeutics, Inc.
ISR / Perspective Therapeutics Inc
RCKT / Rocket Pharmaceuticals, Inc.
KRYS / Krystal Biotech, Inc.
RZLT / Rezolute, Inc.
CYTK / Cytokinetics, Incorporated
AMYLYX PHARMACEUTICALS INC / CALL Call (03237H901)
VKTX / Viking Therapeutics, Inc.
ACET / Adicet Bio, Inc.
PLRX / Pliant Therapeutics, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
DXCM / DexCom, Inc.
ALPN / Alpine Immune Sciences, Inc.
MGNX / MacroGenics, Inc. Call
NAMS / NewAmsterdam Pharma Company N.V.
BOLD / Boundless Bio, Inc.
BHVN / Biohaven Ltd.
ALGS / Aligos Therapeutics, Inc.
JSPR / Jasper Therapeutics, Inc.
MERSANA THERAPEUTICS INC / CALL Call (59045L906)
ZURA / Zura Bio Limited
MORF / Morphic Holding, Inc.
RLMD / Relmada Therapeutics, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
FULC / Fulcrum Therapeutics, Inc.
KPTI / Karyopharm Therapeutics Inc.
MGNX / MacroGenics, Inc.
COGT / Cogent Biosciences, Inc.
WVE / Wave Life Sciences Ltd.
ELUT / Elutia Inc.
SLDB / Solid Biosciences Inc.
GOSS / Gossamer Bio, Inc.
MRSN / Mersana Therapeutics, Inc.
CCCC / C4 Therapeutics, Inc. Call
EYPT / EyePoint Pharmaceuticals, Inc.
ETNB / 89bio, Inc.
KALV / KalVista Pharmaceuticals, Inc.
SRRK / Scholar Rock Holding Corporation
KOD / Kodiak Sciences Inc.
URGN / UroGen Pharma Ltd.
SLNO / Soleno Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
CERS / Cerus Corporation
MODD / Modular Medical, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
CLDX / Celldex Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
ADCT / ADC Therapeutics SA
ALXO / ALX Oncology Holdings Inc. Put
LBPH / Longboard Pharmaceuticals, Inc.
TERN / Terns Pharmaceuticals, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
VCYT / Veracyte, Inc.
EVGN / Evogene Ltd.
TARS / Tarsus Pharmaceuticals, Inc.
MLYS / Mineralys Therapeutics, Inc.
CCCC / C4 Therapeutics, Inc.
ENGN / enGene Holdings Inc.
BIIB / Biogen Inc.
PCVX / Vaxcyte, Inc.
BDSX / Biodesix, Inc.
HLXB / Helix Acquisition Corp. II
TELA / TELA Bio, Inc.
PSTX / Poseida Therapeutics, Inc.
NUVL / Nuvalent, Inc.
IRON / Disc Medicine, Inc.
RNA / Avidity Biosciences, Inc.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
TRVI / Trevi Therapeutics, Inc.
ERAS / Erasca, Inc.
CGEN / Compugen Ltd.
ORIC / ORIC Pharmaceuticals, Inc.
MTEM / Molecular Templates, Inc.